Russell Investments Group
VBIV

Russell Investments Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Russell Investments Group’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-539
Closed -$1.77K – 3648
2023
Q2 		$1.77K Hold
539
– – ﹤0.01% 3261
2023
Q1 		$4.9K Hold
539
– – ﹤0.01% 2944
2022
Q4 		$6.33K Hold
539
– – ﹤0.01% 2856
2022
Q3 		$11K Sell
539
-147
-21% -$3.96K ﹤0.01% 2858
2022
Q2 		$16K Hold
686
– – ﹤0.01% 2816
2022
Q1 		$34K Buy
+686
New +$33.9K ﹤0.01% 2654
2018
Q2 		– Sell
-16,382
Closed -$1.72M – 2977
2018
Q1 		$1.72M Buy
16,382
+1,120
+7% +$134K ﹤0.01% 1938
2017
Q4 		$1.96M Buy
15,262
+3,758
+33% +$462K ﹤0.01% 1823
2017
Q3 		$1.33M Buy
+11,504
New +$1.38M ﹤0.01% 1991

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Russell Investments Group's VBIV Position: Q3 2023 in Review

Russell Investments Group sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2023, closing a stake of 539 shares — an estimated $1.77K sold.

Russell Investments Group first reported a position in VBIV in Q3 2017 and held it in 9 quarters. The position peaked at $1.96M in Q4 2017. 37 funds tracked by Wall St. Rank hold VBIV as of Q3 2023.

  • Russell Investments Group reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2023 after selling out during the quarter.
  • Russell Investments Group sold 539 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2023, an estimated $1.77K.
  • Russell Investments Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2017 and held it in 9 quarters.
  • Russell Investments Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $1.96M in Q4 2017.
  • 37 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2023.

Based on Russell Investments Group's 13F filing for Q3 2023, filed 13 Nov 2023.